← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Opera Bioscience, Inc.
Evanston, IL
$1,847,638
Total funding
3
Grants
Funding over time
peak $1.3M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NSF$1,523,994 · 2
NIH$323,644 · 1
By mechanism
—$1,523,994 · 2
R43$323,644 · 1
Investigators at Opera Bioscience, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
SBIR Phase II: A Gram-Negative Bacterial Secretion Platform for Cost-Effective, High-Purity Recombinant Protein Production$1,248,994
· FY2025 · TIP
A new platform for inexpensive and scalable recombinant protein and growth factor production to support cell culture applications in therapeutics.$275,765
R43 · FY2024 · GM
SBIR Phase I: A low-cost, bacterial production platform for the manufacturing of high purity recombinant proteins and growth factors$275,000
· FY2023 · TIP
A new platform for inexpensive and scalable recombinant protein and growth factor production to support cell culture applications in therapeutics.$47,879
R43 · FY2025 · GM